However, during the progression of prostate cancer, the acquisition of this androgen independence can occur via loss of androgen receptor expression or via other mechanisms that make the receptor active independently of androgens, i.e., gain-of-function mutations in the receptor [31,32]. This evidence concerns the gene AR and prostate cancer.